SQZ Biotechnologies Co. (SQZ): Price and Financial Metrics
SQZ Price/Volume Stats
| Current price | $0.44 | 52-week high | $3.56 |
| Prev. close | $0.27 | 52-week low | $0.25 |
| Day low | $0.38 | Volume | 30,210,700 |
| Day high | $0.57 | Avg. volume | 455,220 |
| 50-day MA | $0.55 | Dividend yield | N/A |
| 200-day MA | $1.24 | Market Cap | 12.83M |
SQZ Stock Price Chart Interactive Chart >
SQZ Biotechnologies Co. (SQZ) Company Bio
SQZ Biotechnologies Co. is a clinical-stage biotechnology company, which engages in developing cell therapies for patients with cancer, infectious diseases, and other serious conditions. It operates through SQZ Cell Therapy Platform, which uses membrane disruption to deliver material into cells. The company was founded by Robert S. Langer Jr., Klavis F. Jensen, Agustin Lopez Marquez, and Armon Sharei in March 2013 and is headquartered in Watertown, MA.
SQZ Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -96.72% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -91.71% |
| 2021 | -69.19% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...